Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting: A Midazolam-controlled Randomized Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06752759
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:02.988287+00:00
Published At
2026-04-24T00:00:00+00:00
Record Updated At
2026-04-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Severe Depression", "Moderate Depression", "Ketamine", "Midazolam", "Peripheral Nervous System Agents", "Central Nervous System Agents", "Neurotransmitter Agents", "Physiologic Effects of Drugs", "Sensory System Agents", "Analgesics, Non-Narcotic", "Anti-Inflammatory Agents, Non-Steroidal", "Depressive Symptom", "Hypnotics and Sedatives", "Anti-anxiety Agents", "Tranquilizing Agents", "Psychotropic Drugs", "Anesthetics Agent"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-24"
protocolSection.identificationModule.nctId
"NCT06752759"
protocolSection.identificationModule.officialTitle
"Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting: A Midazolam-controlled Randomized Controlled Trial"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Severe Depression (protocolSection.conditionsModule.conditions)
  • Moderate Depression (protocolSection.conditionsModule.conditions)
  • Ketamine (protocolSection.conditionsModule.conditions)
  • Midazolam (protocolSection.conditionsModule.conditions)
  • Peripheral Nervous System Agents (protocolSection.conditionsModule.conditions)
  • Central Nervous System Agents (protocolSection.conditionsModule.conditions)
  • Neurotransmitter Agents (protocolSection.conditionsModule.conditions)
  • Physiologic Effects of Drugs (protocolSection.conditionsModule.conditions)
  • Sensory System Agents (protocolSection.conditionsModule.conditions)
  • Analgesics, Non-Narcotic (protocolSection.conditionsModule.conditions)
  • Anti-Inflammatory Agents, Non-Steroidal (protocolSection.conditionsModule.conditions)
  • Depressive Symptom (protocolSection.conditionsModule.conditions)
  • Hypnotics and Sedatives (protocolSection.conditionsModule.conditions)
  • Anti-anxiety Agents (protocolSection.conditionsModule.conditions)
  • Tranquilizing Agents (protocolSection.conditionsModule.conditions)
  • Psychotropic Drugs (protocolSection.conditionsModule.conditions)
  • Anesthetics Agent (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.